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Aptamers are single-stranded, synthetic oligonucleotides that fold into 3-dimensional
shapes capable of binding non-covalently with high affinity and specificity to a target
molecule. They are generated via an in vitro process known as the Systematic
Evolution of Ligands by EXponential enrichment, from which candidates are screened
and characterized, and then used in various applications. These applications range
from therapeutic uses to biosensors for target detection. Aptamers for small molecule
targets such as toxins, antibiotics, molecular markers, drugs, and heavy metals will
be the focus of this review. Their accurate detection is needed for the protection and
wellbeing of humans and animals. However, the small molecular weights of these targets,
including the drastic size difference between the target and the oligonucleotides, make it
challenging to select, characterize, and apply aptamers for their detection. Thus, recent
(since 2012) notable advances in small molecule aptamers, which have overcome some
of these challenges, are presented here, while defining challenges that still exist are
discussed.
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INTRODUCTION
While DNA is generally known as the biological macromolecule responsible for the storage of
hereditary information, it can also act as an affinity probe or molecular recognition element for
a variety of applications from therapeutics to biosensing. A DNAmolecule which functions as such
is termed an aptamer. Aptamers are single-stranded, synthetic oligonucleotides (DNA or RNA)
which fold into 3-dimensional shapes capable of binding non-covalently and with high affinity to
a target molecule. They can bind with such specificity that they can differentiate enantiomers and
molecules that differ by as little as one functional group. Aptamers are generated via an in vitro
process known as the Systematic Evolution of Ligands by EXponential enrichment, also known as
SELEX. Tuerk and Gold (1990), aiming to find an RNA aptamer sequence that would bind T4 DNA
polymerase, first termed the process. Many variations were made to the original SELEX process to
better suit the needs of the researcher. Overall, however, SELEX is made up of three main steps:
selection, partitioning, and amplification (Figure 1).
The selection step involves the incubation of an oligonucleotide library with a target molecule.
The library generally consists of up to 1016 different sequences (Ellington and Szostak, 1990; Tuerk
and Gold, 1990) each containing a random region flanked by two known sequence regions. The
library can be tagged (radiolabel, fluorophore, etc.) to allow for monitoring, although depending
on the SELEX method, this is not always necessary. The length of the random region varies based
on a balance of three parameters: size of target, cost, and diversity. While a recent analysis of all
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FIGURE 1 | Overview of the SELEX process. SELEX begins with an oligonucleotide library consisting of ∼1016 different sequences. The library is then incubated
with the target (1). Some sequences will bind to the target and others will not. Sequences that have bound to the target are then separated from those that have not
(2). After separating the sequences from the target, the sequences are copied and amplified using polymerase chain reaction (3). Sequences are then reintroduced
into the process several times before being sequenced via either high throughput or low throughput sequencing.
reported selection experiments from 1990 to 2013 showed no
statistically significant correlation between template length and
affinity when all target types were examined together (McKeague
et al., 2015b), it has been suggested that it may be better to have a
library of short sequences for smaller molecules to try to close the
size gap between the aptamer and small molecule, such as to limit
crowding and increase selection efficiency (Neves et al., 2015).
Also, the longer the sequence, the harder and more expensive it
will be to synthesize. However, the longer the random region,
the more possible conformations that the aptamer can adopt
and the better the chance of finding an aptamer for the target
(Nieuwlandt, 2000).
The partitioning phase involves the separation of sequences
that have bound to the target from those that did not bind. There
are numerous methods for performing this step, depending on
the type of SELEX chosen. These methods are essentially mass-
based or wash-based.Mass-basedmethods, such as size-exclusion
filtration, rely on a distinguishable difference in mass of the
aptamer upon complex formation that can be exploited for
partitioning (Ozer et al., 2014). Wash-based methods require the
immobilization of either the target or the oligonucleotide library,
such that washes with solution would separate sequences that
bound from those that did not.
Finally, amplification involves making an abundance of copies
of the sequences that have bound to the target using polymerase
chain reaction. The known flanking regions on each sequence
make up the primer-binding sites to allow amplification. Since so
few library sequences are recovered following partitioning, copies
are required to make up the enriched library for continuation to
the next round.
This three-step process is usually repeated several times
with continuously changing conditions to allow for increased
stringency. Only sequences with high affinity to the target would
be able to bind in more stringent conditions. However, it is
recommended to increase stringency after the first few rounds.
Initially, the oligonucleotide pool is quite diverse, with many
sequences in low frequency, which run the risk of being lost in
the early rounds.
Aptamers can be used in a wide range of applications due
to their unique properties. As such, fields such as medicine,
cell and microbiology, and analytical chemistry are interested
in aptamers for their potential use in drug development, cell
tracking and viral and bacterial detection, and chromatographic
separation, respectively (Sefah et al., 2009). In particular,
aptamer-based biosensors and assays are being investigated as
possible alternatives to conventional antibody-based technology.
Aptamers are highly comparable to antibodies, in that they both
bind to their targets with high affinity and selectivity. Nowadays,
antibodies are the gold standard for use in biosensors or as
drug components, however, aptamers have been increasing in
popularity since their introduction in the early 1990s due to
their advantageous properties. Unlike antibodies, aptamers are
synthesized in vitro, which is not only a more ethical approach
than using animals or cell cultures but also substantially less
expensive and with little-to-no discrepancies between batches
(Smith et al., 2007). In addition, aptamers have much longer shelf
life than antibodies and are stable over a wide range of conditions;
for example, while aptamers can renature following exposure
to high temperatures, antibodies are irreversibly denatured.
By exploiting these properties, one can select for aptamers
in the conditions under which the aptamer would eventually
be used, a unique benefit. Furthermore, due to the in vitro
process aptamers can be selected for molecules that do not
elicit an immune response; a circumstance which is necessary
Frontiers in Chemistry | www.frontiersin.org 2 May 2016 | Volume 4 | Article 14
Ruscito and DeRosa Aptamers for Small Molecules
for antibody production. However, drawbacks to aptamers do
exist. Aptamers have an overall negative charge making them
hydrophilic, and are rapidly degraded by nucleases. With the
exception of modified aptamers such as SOMAmers (Slow Off-
rate Modified Aptamers; Rohloff et al., 2014), aptamers only
contain 4 nucleic acid building blocks compared to the 22
amino acid building blocks of proteins, limiting their diversity of
possible secondary and tertiary structures. Some drawbacks can
be overcome, such as modifying the aptamer backbone or adding
particular functional groups to increase their stability (Mayer,
2009; Tolle and Mayer, 2013). However, while SOMAmers and
other modified aptamers offer more diversity and stability,
custom synthesis adds to the costs.
Recently there has been an increase in demand for the
detection of small molecules (<900.0 g/mol). These molecules
include toxins, antibiotics, molecular markers, drugs, heavy
metals, and ions. Industries such as pharmaceutical/medical
require the quick and sensitive detection of small molecules
such as molecular markers of disease, drugs, or metal ions
for monitoring of human and animal health. The agriculture
industry requires measuring levels of mycotoxins and heavy
metals, among others, to ensure food safety. The detection of
drugs is of great importance for forensic analysis as well. Because
there is increasing need for small molecule detection, there
must be a detection method that is sensitive, reliable, affordable,
ideally portable, and simple to use. Aptamer-based sensors are
becoming a promising alternative to conventional methods for
small molecule detection. However, compared to the number
of aptamers for larger target molecules (proteins, cells, etc.)
reported in the literature, there are very few for small molecules.
Only 25% of all reported aptamer selections from 1990 to 2013
were for small molecule targets (McKeague et al., 2015b). As
will be discussed in upcoming sections, this discrepancy can be
attributed in large part to technical challenges that affect selection
and characterization.
This review exposes the challenges associated with small
molecule aptamer selection, characterization, and aptamer-based
detection systems. This topic has been reviewed previously
(McKeague and DeRosa, 2012) and this review will serve as
a follow up which will focus on the highlights and effort
put forth by the research community since 2012 to overcome
several of the challenges in each stage of the aptamer process
to increase efficiency and likelihood of success. Highlights
include new methods for selecting small molecule aptamers,
a workflow comprising the methods and assays for aptamer
screening, characterization, and functional verification, methods
for aptamer truncation, and also the application of aptamers
into various types of sensors which were previously difficult or
unsuitable for small molecule aptamers.
SELECTION (SELEX) OF
SMALL-MOLECULE BINDERS
An examination of published selection data from 1990 to 2013
confirmed that aptamers selected for small molecule targets
have lower affinity than those selected for other targets, on
average (McKeague et al., 2015b). While the reasons for the
poorer performance of small molecule aptamers remain to
be elucidated, several technical challenges associated with the
SELEX experiment are thought to play a role. One of the main
challenges of performing SELEX with a small molecule target is
the partitioning of bound and unbound sequences. The small
size of the target does not lead to extensive mass difference
between unbound aptamer and bound complex, complicating
the separation process. As a result, small molecule selections
typically involves immobilization of one of the biomolecules.
Although there are a variety of current SELEX methods
suited for small molecules (McKeague and DeRosa, 2012), they
mostly stem from two main types, namely conventional/Flumag
and Capture/structure-switching. Conventional SELEX was first
performed by Ellington and Szostak (1990) for the selection
of aptamers against organic dyes. This process involves the
conjugation of the target to a solid support matrix, sepharose
for example. Sequences that bind the target were separated from
those that do not bind with multiple washes, then the sequences
were subsequently eluted from the beads and amplified using
polymerase chain reaction for the next round. With this method,
the oligonucleotide pool is unmodified and free in solution,
which eliminates complications involved in conjugating the pool
to the bead. On the other hand, sepharose is not an ideal solid
support as a large concentration of target is required for loading.
Flumag SELEX was first performed by Stoltenburg et al. (2005)
as proof-of-concept for the selection of aptamers against the
protein streptavidin.What defines this method is the conjugation
of the target on magnetic beads, which allows for more rapid
selections. Relative to agarose and sepharose beads, magnetic
beads are much more expensive, yet much less target is required
to load the magnetic beads. The lower the amount of target, the
more competition there is amongst the sequences in the pool,
resulting in the selection of high affinity binders (Nieuwlandt,
2000; Stoltenburg et al., 2005). However, by immobilizing the
target, the selection is being performed on a conjugate rather than
the target alone. Under these circumstances, non-specific binding
may take place, and the affinity may be negatively affected in
future applications if target is free in solution.
From the two aforementioned SELEX methods, many more
methods were developed. An often-used method is Structure-
Switching or Capture SELEX; structure-switching SELEX was
invented by Nutiu and Li (2003) for the selection of aptamers
against the four standard NTPs. It is the opposite of Flumag
SELEX with regards to target immobilization, and relies
on a conformational change in the aptamer sequence upon
target binding, coined as “structure-switching.” Rather than
immobilizing the target to the solid support matrix of choice,
a fluorescent oligonucleotide pool is tethered and the target is
free in solution. To tether the pool to the matrix, a docking
sequence complementary to a known region on every strand
is conjugated to the matrix. The strand is bound to the
docking sequence and the pool-labeled beads are exposed to the
target. Only the sequence that changes structure conformation
upon binding to the target will effectively release itself from
the dock. Sequences found in solution following incubation
with target are sequestered and amplified in preparation
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for the next round. Capture SELEX is ideal for molecules
that are difficult to immobilize, such as small molecules. In
addition, it provides high detection specificity (Stoltenburg
et al., 2012); in order to overcome the attraction to the
docking sequence, there must exist a sizeable change in the
secondary and tertiary structure of the oligonucleotide upon
target interaction. As will be discussed in future sections, this
structural change can be exploited, as many characterization
and sensor development methods rely on structural changes
upon binding to target to be effective. However, tethering
the oligonucleotide pool may have repercussions after SELEX
if the potential aptamers are to be used free in solution
in the downstream application, as the change in shape and
conformation might not be the same, thus affecting the binding
affinity of the aptamer.
Both conventional and capture SELEX have been used to
select small-molecule binding aptamers successfully. However, in
an attempt to overcome various complications associated with
small molecule SELEX, the following advances have recently been
made.
To address the large size difference between the small
molecule and the aptamer, Handy et al. (2013) made use
of a hapten-protein carrier bound to the target of interest,
saxitoxin (MW: 299.3 g/mol). Saxitoxin is a marine toxin
responsible for human syndrome paralytic shellfish poisoning.
This concept was previously employed in an attempt to increase
the immunogenicity of saxitoxin for the production of anti-
saxitoxin antibodies. The already-established reaction for target
immobilization involves the protein carrier keyhole limpet
hemocyanin which is reacted to the target via a linker, Jeffamine.
Keyhole limpet hemocyanin is subsequently conjugated to epoxy
functionalized magnetic beads via the amine end. The need
for protection of other functional groups was not required,
thus simplifying the surface chemistry involved. By conjugating
saxitoxin to the protein, saxitoxin is essentially converted to a
large molecule, thereby closing the gap in the size difference
between saxitoxin and the sequences, and increasing the chances
of finding an aptamer. Another advantage to using a protein is
the ability to evaluate the conjugation efficacy of the protein-
target complex to the bead before selection. In this case, the beads
with and without the protein-target complex were subjected to
endoprotease trypsin, and the resulting peptides were analyzed
using LC-MS/MS. Thismethod confirmed successful conjugation
to the beads. Conjugating the target directly onto the beads
is possible but requires an alternative method for confirming
conjugation, such tracking the target with a label or with their
inherent fluorescence or inherent absorption in the UV-Visible
spectrum.
This method successfully selected an aptamer for saxitoxin,
with the aptamer binding in a concentration-dependent manner.
Since the small molecule was essentially converted to a larger one,
the protein addition was a relatively inexpensive solution to the
size difference problem of small molecules and sequences. The
drawback of this method, however, is that aptamers are selected
for a conjugate rather than a small molecule alone. Nevertheless,
the involvement of the protein proved to be valuable by easing
conjugation and allowing for coupling evaluation.
Another promising variation of small molecule SELEX was
performed by Martini et al. (2015). In order to evade the issues
surrounding target or oligonucleotide pool immobilization, this
variation of small molecule SELEX involves the use of an RNA
library based on the structure of a riboswitch. Riboswitches
are aptamers found in nature that change conformation upon
binding to a ligand, thereby exposing a sequence in which a
protein could bind and initiate a biochemical process. The team
Martini et al. utilized a synthetic library version of a variant
riboswitch for thiamine pyrophosphate (TPP, MW: 425.0 g/mol),
a coenzyme and essential vitamin. This library was modified
from the original riboswitch, such that four regions responsible
for ribozyme activity were randomized, and the RNA pool and
TPP are free in solution. Upon binding of a sequence to the
target, a change in conformation of the sequence is exhibited,
exposing an area for a short double stranded biotin-labeled DNA
reporter with a complementary sequence to bind (Figure 2).
Upon binding to the RNA sequence, a strand on the reported
is displaced. Sequences which have bound to the reporter are
isolated with streptavidin beads whereas those that do not change
conformation cannot bind the biotin-labeled reporter and thus
are discarded. Using this approach, only three rounds were
required to obtain a high affinity RNA aptamer for TPP. The
pools were sequenced and strand displacement was monitored
with a fluorophore-quencher reporter (in place of the biotin-
labeled reporter) after every round to monitor enrichment and
activity, respectively.
Sequence diversity was decreased after the first selection
round whereas displacement activity increased. In fact, the
sequence which represented a large part of the pool in the
final round had the highest level of displacement activity. In
this situation, due to the exposure of previously obstructed
sequence upon target binding, free equilibrium binding can
take place between the strands and the target, followed by the
capture and immobilization onto a bead only after the binding
has taken place. Therefore, the usual complications involved
in immobilizing the target or the pool such as non-specific
binding, complicated surface chemistry, the possible change in
affinity to target when not immobilized, are no longer of concern.
In addition, after SELEX is terminated and multiple sequences
are chosen for further testing, this can be further adapted as
a screening method for characterizing potential aptamers and
ultimately as a biosensor.
Quite commonly, 10 ± 6 (McKeague et al., 2015b) SELEX
rounds are performed before the process is stopped and high
affinity binders are screened. The lack of direct affinity and
specificity monitoring after each round prevents one from
knowing if and when the pool is being enriched, as well as if the
sequences in the pool have high specificity to the target. Good
binders may appear earlier than thought possible and thus costs
and time expended for extra rounds would be futile, particularly
if high affinity and specificity binders are not obtained in the
end. Thus, in an effort to determine if selections with small
molecules can be terminated early in the process, Spiga et al.
(2015) performed capture SELEX in combination with SPR and
Illumina high throughput sequencing to develop an aptamer for
the antibiotic tobramycin (MW: 467.5 g/mol). Capture SELEX for
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FIGURE 2 | A type of structure-switching SELEX for aptamer selection. A sequence is folded in such a way that a binding site (yellow-blue) is hidden. Once
target is introduced and bound to the sequence, the sequence undergoes a structural shift that exposes the binding site, such that a biotin-labeled double-stranded
DNA reporter is free to bind to the site. Since the reporter preferentially binds to the binding site on the sequence, the shorter strand on the reporter becomes
displaced. Thus, the sequence that binds the target and results in a structural shift becomes labeled with a biotin reporter. The sequence is then sequestered and
separated from non-binding or non-shifting sequence structures with a streptavidin-conjugated magnetic bead.
small molecules can be time consuming and arduous due to the
many rounds that must be performed. To determine when and
which high affinity binders emerge at high frequency in the pool,
SPR and high throughput sequencing were performed following
each round of SELEX in order to assess binding to the target and
for sequencing for enrichment analysis, respectively. The high
throughput sequencing allows for quantitative determination of
each sequence in the pool and also its enrichment relative to
previous rounds. By using SPR and sequencing, the binding and
pool enrichment for the target was directly monitored without
waiting until the end of SELEX. By doing so at every round,
a clear understanding of how well the pool is responding to
the target was provided, such that SELEX could be ended when
enrichment peaks and when there is sufficient binding to the
target. In most cases, enrichment is determined indirectly based
on how much of the library is eluted compared to a control.
This approach is not always accurate as there is no measure of
affinity of the pool to target or pool complexity. Ending SELEX
prematurely results in a pool that is insufficiently enriched,
thus the best aptamers may not be found. Alternatively, if too
many rounds are performed and conditions are too stringent,
high affinity aptamers may be lost and never recovered. Also,
more rounds are associated with frequent pool amplifications
that can skew the pool due to polymerase chain reaction bias.
The researchers of this study found sequence convergence and
maximal binding at round 12, however sequence families specific
for the target began to emerge in round 8 where binding was
observed. In addition, the enriched sequences which made up
the bulk of the pool in the last round (round 12) were found to
be the most enriched of much earlier rounds. In the end, high
affinity aptamers for tobramycin that were comparable to existing
tobramycin aptamers were obtained. Although the sequencing
can be quite costly, it is highly likely that the cost will only
decrease as this method becomes more common.
Another challenge associated with the selection of aptamers
for small molecules is the lack of epitopes or functional
groups available for strong aptamer binding. In the case of
monosaccharides glucose, fructose, and galactose (each MW:
180.1 g/mol), abnormal levels in the blood may be associated
with illness and disease, thus it is crucial to be able to monitor
them. Unfortunately, they all have similar structures with the
same hydroxyl groups spatially arranged only slightly differently
as the epitopes. This makes it difficult not only to select
an aptamer that binds well but also that binds with high
specificity. Organic or organometallic receptors were initially
incorporated with aptamers to help resolve this issue and
promote the interaction of the aptamer with the target, however
the receptors instead interfered with binding. Nevertheless,
Yang et al. (2014) used the receptors for the selection of
aptamers for the aforementioned monosaccharides but in a
different manner. Rather than combining the receptor with the
aptamer, the receptor, specifically Shinkai’s glucose fluorescent
receptor, was first combined with the sugars to form a complex
then added to an oligonucleotide pool for selection. The
library was bound to an agarose streptavidin column via a
biotinylated complementary oligonucleotide and the receptor
and target, which already formed a complex, were added to
the mixture. Sequences that bound the complex, having formed
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a ternary complex, dissociated from the complement on the
column. Following counter-selections against the receptor and
the selection of high affinity aptamers, a sensor was easily
established due to the structure–switching selection method.
In this method, the sensor is composed of a fluorescently-
labeled aptamer bound to a quencher-labeled DNA strand. Upon
addition of the target-receptor complex, the aptamer dissociates
from the quencher strand and binds the complex, thereby
restoring fluorescence of the aptamer and acting as a visible signal
for the presence of target. The aptamers for each monosaccharide
had high specificity as a result of the counter-selections that were
performed against the receptor alone and the other sugars with
the receptor. Furthermore, counter-selections were run against
a mixture of steroids to remove any hydrophobic three-way
junctions which are known to dominate selection experiments
(Kato et al., 2000; Laing and Juliano, 2015). These methods
were found to be successful in the selection of aptamers for
monosaccharides that lack suitable epitopes for aptamer binding.
This technique could be applicable for other small molecules
which do not contain suitable functional groups for binding of
aptamers during selection.
These are only a few methods from the past few years where
researchers have modified SELEX and oligonucleotide structure
to better select aptamers for small molecule targets. Although
some limitations are still present, there have been considerable
contributions to overcoming certain challenges that hinder
SELEX for small molecules. They allow for better selections, thus
yielding high affinity binders. Nonetheless, there is always room
for improvement and more research.
Presented here is a list of aptamers for small molecules
with their associated Kd that have been selected in the past
3 years (Table 1). A comprehensive list of aptamers for small
molecules before and including 2012 can be found in the review
by McKeague and DeRosa (2012).
CHARACTERIZATION OF
SMALL-MOLECULE BINDERS
Screening and characterizing aptamers for small molecules is
difficult; there are no universally accepted guidelines, making
it challenging to choose the right assay for accurate affinity
measurements. In addition, aptamers are considerably larger
than small molecules, which can lead to high signal/noise ratio
in size-based measurements, thus only sensitive assays will be
able to detect their interaction. Current assays which have been
demonstrated to effectively measure aptamer-target interactions
include surface plasmon resonance (SPR), isothermal titration
calorimetry (ITC), fluorescence polarization/anisotropy (FA/FP),
and capillary electrophoresis (CE), however each assay has its
own set of limitations and not all are suitable depending on the
downstream application of the aptamer.
In this section, descriptions of innovative methods which
overcome some of the current limitations are presented.
To begin, McKeague et al. (2015a) have tested and compared
a variety of affinity assays, in an effort to streamline the workflow
for screening and characterizing the binding of aptamers to small
molecules. For their experiments, they chose the small molecule
ochratoxin A (OTA, MW: 403.8 g/mol), a food-contaminating
fungal toxin, and multiple previously reported OTA aptamers.
The use of different aptamers for the same target allowed for
comparisons amongst them as well. The aptamers were put
through a panel of binding assays, including equilibrium dialysis,
ultrafiltration, affinity chromatography with magnetic beads,
fluorescence polarization, SPR (Chang et al., 2014), a modified
DNase I protection assay (Frost et al., 2015), a SYBR green
displacement assay (SG), and a gold nanoparticle protection assay
(AuNP). Notably, no one aptamer performed equally well over
all the different assays; authors reported inconsistencies in the
binding affinities (Kds) between the different assays when the
same aptamer was used. Furthermore, although all aptamers
displayed binding to OTA in at least one assay, the strength of
their interaction widely varied across the different assays, with the
binding of several aptamers with certain assays not detectable. As
a result, it was deemed that it would be favorable to use multiple
assays when characterizing small molecule aptamers, in order to
overcome any inherent limitations of individual characterization
approaches. Some assay limitations include immobilization of
either the aptamer or the target, use of labeling, cost, lack of
sensitivity inability to measure binding quantitatively, or the
involvement of complicated surface chemistry. As an example,
the magnetic bead test involves target immobilization, which can
create steric hindrance and impair binding due to the blocking
of an original exposed site on the target. Thus, performing
an additional test in which the target and aptamer are free
in solution and thereby allowing free movement, for example
the DNase I protection assay (see below) allows for a fuller
assessment of the functionality of the aptamer. Ultimately, due to
limitations in each assay, inconsistencies in Kds between different
assays, and to confirm the functionality of the aptamer, it is
highly recommended to select assay conditions which mimic
the desired application of that aptamer. In this way, by not
drastically changing binding conditions, the measured binding
affinity becomes a truer indication of how the aptamer will
perform in the downstream sensor, or other application.
To improve aptamer development, McKeague et al. designed
a workflow which comprises the methods, assay considerations,
and assay options for aptamer screening, characterization, and
functional verification once the SELEX process is complete and
several aptamer candidates have been revealed by sequencing.
The workflow sets out suggestions for appropriate combinations
of assays for use in (1) the initial screening of aptamer sequenced,
(2) truncation of aptamers, (3) Kd characterization, and (4)
functional validation. For example, screening methods such as
FP, SG, AuNP, and affinity chromatography with magnetic beads
were recommended for their dependability, rapidity, and cost
effectiveness. By following this workflow diagram, the screening
can be done efficiently, the aptamer affinity can be quantified,
and one can have some confidence that the chosen aptamers will
perform well in the downstream application.
Despite the inherent challenges with the characterization
of small molecule-binding aptamers, recently, there have been
several promising advances. In particular, characterization
methods which have been proven effective for characterizing
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TABLE 1 | Aptamers selected for small molecules from 2012 to 2015 and their respective Kd or limit of detection (LOD).
Aptamer Target RNA/DNA Kd or LOD References
(Z)-4-(3,5-difluoro-4-hydroxybenzylidene)-1,2-
dimethyl-1H-imidazol-5(4H)-one
(DFHBI)
RNA 360 nM Filonov et al., 2014
17β-estradiol DNA 0.9 µM Vanschoenbeek et al., 2015
17β-estradiol DNA 50 nM Alsager et al., 2014
Aflatoxin B1 DNA 11.39 ± 1.27 nM Ma et al., 2014
Aflatoxin B2 DNA 9.83 ± 0.99 nM Ma et al., 2015
Aflatoxin B1 DNA 96.6 ± 8.6 nM Malhotra et al., 2014
Aflatoxin M1 35.6 ± 2.9 nM
Anatoxin-A DNA 81.3 ± 8 nM Elshafey et al., 2015
Atrazine DNA 0.62 ± 0.21 nM Williams et al., 2014a
Benzylguanine RNA 219.1 ± 7.8 nM Xu et al., 2016
Brevetoxin-2 DNA 42 nM Eissa et al., 2015
Bromacil DNA 9.6 ± 7.8 nM Williams et al., 2014b
Cd (II) DNA 34.5 nM Wu et al., 2014
Danfloxacin RNA 2.99 ± 2.12 nM Han et al., 2014
Fumonisin B1 DNA 62 ± 5 nM Chen et al., 2014a
Kanamycin A DNA 3.9 µM Stoltenburg et al., 2012
Kanamycin A DNA 2.8 µM Nikolaus and Strehlitz, 2014
Ketamine DNA 0.59 µM Sun et al., 2014
Lysergamine DNA 73 nM Rouah-Martin et al., 2012
Malathion DNA 1.14 ± 0.7nM Williams et al., 2014c
Methamphetamine DNA 100.2 ± 16.9 nM Ebrahimi et al., 2013
N-methyl mesoporphyrin (NMM) DNA 0.88 ± 0.12 µM Yang and Bowser, 2013
Ochratoxin A DNA 110 ± 50 nM McKeague et al., 2014
Okadaic Acid DNA 77 nM Eissa et al., 2013
Okadaic acid DNA 1.05 nM Lin et al., 2015
Organophosphorus pesticides DNA Phorate: 1.11 µM Wang et al., 2012
Profenofos: 1 µM
Isocarbophos: 0.83 µM
Omethoate: 2 µM
Oxytetracycline DNA 4.7 nM Kim et al., 2014
Pd II DNA 4.60 ± 1.17 µM Cho et al., 2015
Polychlorinated biphenyls DNA 4.02 ± 0.54 µM Xu et al., 2012
Polychlorinated biphenyls DNA 66.36 ± 7 nM Mehta et al., 2012
99 ± 12 nM
Progesterone DNA 9.63 ± 3.12 nM Contreras Jiménez et al., 2015
T-2 toxin DNA 20.8 ± 3.1 nM Chen et al., 2014b
Tebuconazole, inabenfide, and mefenacet DNA Inabenfide: 191 nM (LOD) Nguyen et al., 2014
tebuconazole 128 nM (LOD)
mefenacet: 276 nM (LOD)
Tobramycin DNA 150 nM Spiga et al., 2015
Zearalenone DNA 29 ± 5 nM Chen et al., 2013
Only the aptamer with the lowest Kd or limit of detection is reported.
aptamer binding to larger molecules such as proteins have been
adapted in innovative ways to suit smaller targets.
A notable advance for screening aptamers for small molecules
was made with the use of a nanoporous composite formed by
the sol-gel process. This process will allow for the screening of
aptamers for low molecular weights targets, suitable for the first
step in the aforementioned workflow diagram. The technique
of sol-gel entrapment is compatible with biological molecules
such as aptamers due to its aqueous environment which allows
for the aptamers to function optimally. The silica composite
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employed in this method is made up of many pores of adjustable
size to trap the small molecule target. Silica composites with
pores large enough to trap proteins have already been studied
(Kim et al., 2006), and was recently adapted to work with
small molecule bisphenol A (MW: 228.3 g/mol), a potentially
harmful industrial chemical, by Ahn et al. (2012), with a few
important modifications. The available size range of the pores in
the original approach was limited as pore sizes below a certain
threshold compromised the adhesiveness of the sol-gel matrix
to commonly used surfaces, for example microtiter plates, for
automatization. Therefore, in order to access pores in the size
range that would be suitable for small molecule entrapment,
a new porous silicon substrate was generated and which also
allows the sol-gel composite to attach to any surface. With this
innovation, many surfaces and types of sol-gel solvents can be
used. The aptamer has been shown to freely move within the
complex morphology of the nanostructural composite and reach
the target, and the conventional recovery methods (i.e., heat) of
the aptamers bound to the target can also be used, such that the
aptamers can be quantified or amplified using PCR. This method
does not require the immobilization of either the target or the
aptamer, thereby allowing for free binding. Also, this method
could potentially be used for the selection of aptamers for small
molecules (SELEX) to overcome the issue of attaching either the
target or the DNA pool to a solid support matrix, which could
potentially impact the binding of the aptamer to the target. In
addition, this method can be automated since the porous silicon
sol-gel surface can be used on standard microtiter plate formats.
The labeling of aptamer with a fluorescent probe required for
monitoring is themain weakness of this method. The probe could
potentially affect the folding of the DNA which would impact the
binding to the target, besides adding to fabrication costs.
Another noteworthy method for characterizing aptamers for
small molecules is with the use of backscattering interferometry
(BSI). This method was successfully applied for measuring
aptamer affinity to larger molecules such as proteins but Kammer
et al. (2014) have succeeded with small molecule antibiotics,
specifically tenofovir, epirubicin, ampicillin, tetracycline, and the
hormone/neurotransmitter norepinephrine (MW: 287.2, 543.5,
349.4, 444.4, 169.1 g/mol, respectively). BSI involves the use of
a microfluidic chip, a helium-neon laser, and a charge coupled
device (CCD) array (Figure 3). A channel is etched in the chip
which functions as the optics and a sample holder. The laser
irradiates the sample, the beam is reflected and refracted within
the channel, and exits as a fringe pattern before being detected
with the CCD array. Binding of the aptamer to the target leads to
a refractive index change which results in changes to the fringes’
position, thus allowing for the studying of the binding. Both the
aptamer and target are free in solution and do not require any
labeling; this is possible due to the fact that the BSI signal is based
on the target conformation, dipole moment, and hydration. This
method was shown to produce quantitative Kd values which
matched very well with the Kds obtained from SPR published in
the literature.
An interesting method for characterizing the binding of
aptamers and small molecules, and determining the binding site
on the aptamer, is with the use of MicroScale Thermophoresis
FIGURE 3 | Backscattering interferometry setup for aptamer-target
binding measurements. The target and aptamer are incubated together in a
microfluidic channel. A helium-nexon laser irradiates the sample and the beam
is reflected and refracted within the channel. The laser exits as a fringe pattern
and is detected with the CCD array. Binding of the aptamer to the target
changes the refractive index of the laser and subsequently the fringe pattern,
and as such binding can be studied.
(MST). Entzian and Schubert (2015) performed this method
with adenosine triphosphate (ATP, MW: 507.1 g/mol) aptamers.
The study of how the movements of molecules change over
temperature gradients (hence thermophoresis) is the principle of
MST. The movement in the temperature gradient is dependent
on size, charge, and hydration shell of the molecule. When
the target is introduced and binds to the aptamer, one or
more of those properties changes and alters its movement. The
thermophoresis movement is recorded in thin glass capillaries,
where microscale sized temperature gradients from 2 to 6◦C are
induced by an infrared laser. By focusing on other parameters in
addition to mass, targets of any size can be used and as a result,
the interaction with the aptamer can be measured. This method
can measure affinities in the pM and mM range, which is suitable
since the affinities of aptamers for small molecules are generally
nM or µM. This method offers affinity measurements in real-
time and in under 15 min and can be performed in complex
media, although at times labeling is required.
The researchers have taken this method a step further
and aimed to determine the exact binding site of the target.
Strategically, they used structural analogs of ATP and exposed
them to the ATP aptamer. It was found that the binding affinities
of the aptamer to the ligands varied widely; some ligands
displaying low binding and others displaying no binding at all.
By relating the binding information to the ligand structures, areas
of the structure that had major and minor influences on binding
could be elucidated.
The DNase I footprinting assay is a conventional
characterization assay that can be employed for the study
of aptamer-target binding interactions. Briefly, the binding of
a target molecule to an aptamer could lead to regions within
the oligonucleotide structure that would be protected from
digestion; thus, differences in digestion patterns in the presence
and absence of target are correlated to binding interactions. This
method was previously only used with large molecule targets
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since these changes are more easily observed with larger targets,
until Frost et al. (2015) executed the assay with the aptamer for
small molecule fumonisin B1(MW: 721.8 g/mol); fumonisin B1
is a toxic fungal metabolite that that contaminates maize. This
assay involves target and 5′-fluorescently labeled aptamer free
in solution. Following incubation of the aptamer and increasing
concentrations of target, the enzyme DNase I is added and
partially digests the aptamer since the enzyme highly prefers
cleaving double stranded DNA over single stranded DNA. Only
the cleaved 5′ segments with the fluorescent label are visible
on a gel, where a footprint map is generated. By testing with
various concentrations of target, a binding isotherm can be
created to measure the affinity of the aptamer. Small changes
in band intensities on the gel at different target concentrations
are examined using image analysis to discern any structural
perturbations that occur when the aptamer binds to the small
molecule. Binding to the target results in structural changes in the
aptamer where some areas previously double-stranded become
single-stranded and are thereby digested, resulting in different
fragments than when there is no binding. Thus, this map of
fragments can indirectly provide structural and thermodynamic
information at the site of the interaction. This method is a
relatively quick and affordable assay for characterizing the
binding of small molecules to aptamers. Unfortunately, due
to the small subtle changes in band intensity, a larger error is
associated with the Kd. In addition, the aptamer must be labeled
for monitoring on the gel. Nevertheless, this assay provides the
researcher a method for measuring the interaction of an aptamer
with a small molecule without the possible negative side effects
involved in the immobilization of either molecule. It provides
information on the structure of the aptamer upon target binding
and can also be used as a quick aptamer screening method.
As previously mentioned, the issue of the drastic size
difference between the aptamer and the small molecule is of
concern. One way to overcome this problem is to truncate the
aptamer as much as possible while still retaining the maximum
binding. Researchers Frost et al. (2015) used the DNase I
assay to accomplish this. Not only is this method suitable for
determining the binding affinities of potential aptamerminimers,
this method infers whichminimers to focus on; fluorescent bands
visible on the gel following digestion of the full aptamer are
fragments. The bands with consistent changes in intensity relative
to target concentration are fragments likely directly involved in
the binding interaction with the target. The fragment size can be
determined bymeasuring the distance traveled on the gel, and the
section of the aptamer that size corresponds to that fragment size
can be determined using programs which predict the secondary
structure. As a result, any structures (ex. stem loops) involved
in the binding can also be determined. Alternatively, if digested
bands do not show consistent change in band intensity relative to
target concentration, then binding is not occurring.
Another way for reducing aptamer size while maintaining
high binding to the target is the bioinformatics approach as done
by researchers Sánchez-Luque et al. (2014). Although the target
in this case is not a small molecule, it is still applicable and can
be beneficial for small molecule aptamers. The researchers used
algorithms to fold sequences into their most stable secondary
structure, make predictions on structural position, determine
the preferred site of interactions between the sequence and the
target, and more. The collection of information assists in the
determination of minimer aptamer sequences.
Both the DNase I assay and the bioinformatics approach have
yielded truncated aptamers that maintained maximum binding.
The above-mentioned studies provide structure and
alternatives to conventional methods of characterizing aptamer-
small molecule interactions. Reliable and efficient aptamer
screening methods are vital to avoid excessive costs and time by
testing many sequences. As for characterization, it is worthwhile
to test the Kd using multiple affinity methods to ensure a
precise Kd is obtained. In addition, the method chosen should
match the application in which the aptamer would be used for,
such that the Kd from the test accurately reflects the Kd in the
application.
DETECTION USING SMALL-MOLECULE
BINDERS
Sensitive, affordable, and easy to use detection devices for small
molecules such as toxins, antibiotics, molecular markers, drugs,
and heavy metals are in demand by various industries, including
health care, agriculture, environment, and forensics. This need
is ultimately for the protection and wellbeing of humans and
animals.
A biosensor, a small analytical device involving a biological
molecular recognition element with a physiochemical transducer
(Sefah et al., 2009), can qualitatively or quantitatively detect a
small molecule of interest. The biological component interacts
with a target, and the transducer component converts that
interaction into a measurable signal. The biological component
can be made up of proteins, antibodies, or aptamers and the
success of the sensor is based on the affinity and selectively of the
chosen recognition element. A biosensor that utilizes aptamers
as the recognition element is called an aptasensor. While sensors
are analytical devices, assays are analytical procedures that would
measure quantitatively or qualitatively the small molecule of
interest.
Currently, antibodies are the most popular biological
components for biosensors and assays, greatly overshadowing
other options. Nonetheless, aptamers are slowlymaking their way
into the mainstream because they are robust and reusable, unlike
antibody-based sensors, and their small size means there can be
high density immobilization on the sensing surface.
As previously discussed, when it comes to working with
aptamers and small molecules, the large size difference between
the two is an impediment which can make designing a detection
assay sometimes difficult. For example, it was found via NMR
analysis of aptamer-argininamide interactions that, argininamide
(MW: 173.2 g/mol) is sandwiched between reversed Hoogsteen
and Watson-Crick base pairs and tucked into the aptamer
binding area as if it were a cavity (Lin and Patel, 1996). This
type of encapsulation suggests that the small molecule might
be masked from other probes (Hermann and Patel, 2000). As
such, assays for small molecule detection are generally single-site
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binding configurations, which make sandwich assays with a
secondary aptamer challenging.
Current detection methods for small molecules are often
spectroscopy-based, such as fluorescence polarization, and UV
absorption. There are also separation-based methods such
as HPLC, equilibrium dialysis, affinity chromatography, and
other methods such as thin-layer chromatography (TLC) and
isothermal titration calorimetry (ITC; for a more comprehensive
review please refer to McKeague and DeRosa, 2012). However,
these methods either require labeling, the use of expensive
machinery and equipment, are labor intensive, time consuming,
or experience non-specific binding. In some methods, more than
one limitation exists.
To overcome some of these limitations and to increase
the sensitivity of aptamer-based detection systems for small
molecules, researchers have developed new proof-of-concept
methods or altered longstanding methods. Notable modern
advances, post 2012, are described.
Recently, Yang et al. (2015) developed a blu-ray aptasensor
for the detection of ATP. This method utilizes a blu-ray optical
pickup unit and two types of magnetic nanoparticles (MNPs);
the first MNP contains the ATP aptamer covalently bound
while the other contains a short complementary sequence of the
aptamer (Figure 4). Both MNPs are incubated together, forming
MNP clusters as a result of the binding of the aptamer to the
complementary sequence. Once the target is introduced, the
aptamer, which has a higher affinity for the target than the
complement, will bind to the target and dissociate itself from the
complement. The binding of the aptamer to the target inhibits
MNP clustering; therefore the amount of clustering is inversely
proportional to the concentration of target. To quantitatively
measure the cluster density, transmitted light is collected from
the blu-ray optical pickup unit, and since the optical signal is
related to the rotational dynamics of the MNPs, a measure of the
hydrodynamic size distribution of the clusters can be obtained.
The concentration of ATP was determined by quantitatively
measuring the clustering of the MNPs; the optomagnetic reading
of the cluster size correlates to the concentration of ATP, allowing
for accurate determination of the target concentration. Being very
inexpensive and a small, compact machine, this device has the
potential to become a portable sensor.
A popular method for studying molecular interactions and
detecting the presence of a target is fluorescence anisotropy.
Fluorescence anisotropy is a solution-based method, thereby
allowing free movement of the aptamer and target. With
this technique, a biomolecule must be fluorescently labeled to
monitor the interaction. Polarized light of a specific orientation
is used to excite the fluorophore which then emits light. Only
the light emitted from the molecule with the same orientation
is detected and an anisotropy signal is obtained. High or low
anisotropy signal is dependent on the size of the fluorescent
molecule. In the case of an aptamer and small molecule
target, a fluorescent aptamer will rotate and tumble quickly,
thus the emitted light is not conserved long and yielding
low signal. However, when bound to a protein, the aptamer
becomes a large complex which tumbles slowly, conserving
FIGURE 4 | Blu-ray aptasensor scheme for the detection of target. Two types of MNPs are necessary; one MNP contains an aptamer covalently bound while
the other contains a short complementary sequence of the aptamer. In the absence of target, the two MNPs form clusters as a result of the binding of the aptamer to
the complementary sequence (A). In the presence of target, the MNP with the aptamer will preferentially bind the target than the complement on the other MNP and
thus few or no clusters will form (B). Cluster density can then be measured by the Blu-ray unit.
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the emitting light, and thus yielding a large signal. Thus,
based on mass changes of the fluorophore, this method gives
information on the orientation, mobility, and interaction of
biomolecules.
This method is not always practical with smaller targets as
their small size would not result in a substantial difference
in anisotropy signal. Signal amplification would be necessary
to modify this method to suit small molecules as explained
by researchers Liu et al. (2013) who performed fluorescence
anisotropy with graphene oxide (GO) for ATP (MW: 507.1
g/mol) detection. GO preferentially binds ssDNA and acts as
a scaffold, and also a quencher of fluorophores due to Förster
resonance energy transfer between fluorescein and graphene. By
applying these properties, two versions of FA were executed: (1)
A fluorescently labeled aptamer that binds to GO in the absence
of target results in decrease in fluorescence due to quenching
and a size increase resulting in high anisotropy signal. Once in
the presence of target, the aptamer will preferentially bind to the
target, restoring its fluorescence and forming a complex which is
smaller in size, resulting in a low anisotropy signal; (2) A duplex
formed between a fluorescent DNA probe whose sequence is
complementary to an unlabeled aptamer does not bind to GO
in the absence of target, therefore fluorescence is visible and
anisotropy signal is low. In the presence of target, the aptamer
dissociates from the fluorescent probe to bind the target and the
probe binds to GO. The probe and GO form a large complex
resulting in a high anisotropy signal but the fluorescence is
quenched. Since the probe is the labeled molecule, the interaction
of the aptamer and target is measured indirectly. Regardless, the
difference in signal with and without target in both versions
was found to sufficiently large enough to discern binding. This
method which incorporates GO as a signal amplifier successfully
detected ATP in a rapid fashion, requiring seconds to obtain
a signal and only minutes to reach equilibrium. This method,
which does not rely on a conformational change for the aptamer
has also shown to be highly specific to ATP, and has been shown
to function in serum as well as buffer.
Oligonucleotide-based sensors with one-dimensional
nanostructures are also used for the sensitive detection of small
molecules. For example, Gong et al. (2013) generated a sensor
for the detection of Hg2+ (MW: 200.6 g/mol) using single-walled
carbon nanotubes (SWNTs). The methodology of this sensor is
based on an older report from Das et al. (2011) which used a
SWNTs-based chemiresistor to detect ATP (MW: 507.1 g/mol)
with picomolar sensitivity and high selectivity. In the 2013
study an oligonucleotide PolyT strand has affinity for Hg2+. A
free PolyA strand is hybridized with the PolyT functionalized
SWNTs. The PolyT strand acts as the detection probe, as the
PolyT will structure-switch upon binding Hg2+ preferentially
over the PolyA, resulting in the release of PolyA from the
surface of the SWNT. Hg2+ is sensed by the increase in source
and drain current (or the decrease in resistance) due to the
release of PolyA. This label-free sensor was found to have high
sensitivity, in addition to high selectivity. Compared to other
ions (Ca2+, Mg2+, Mn2+), a much greater decrease in resistance
was observed with Hg2+, thereby confirming the high selectivity
to Hg2+.
Methods such as QCM are generally not performed with small
molecules because their molecular mass is too small and do
not cause a measurable size shift when the aptamer is bound
compared to when aptamer is not bound. With large molecule
targets like proteins, these methods are sensitive and reliable.
Being able to benefit from such sensitive tests would be valuable,
thus researchers have recently taken on the challenge of applying
this method successfully for small molecules. The following
methods of using QCM are not only highly sensitive, but allow
for direct detection of binding in real-time, without the need of
labeling or signal amplification, and can detect minute changes
in mass densities. Özalp (2011), followed by Osypova et al.
(2015), have successfully used QCM coupled with dissipation
monitoring (QCM-D) for the detection of small molecules ATP
(MW: 507.1 g/mol) and a mimic of the amino acid tyrosine, L-
Tyrosinamide (MW: 180.0 g/mol), respectively. The dissipation
monitoring allows for increased sensitivity as it monitors changes
in resonance frequency and variations in energy dissipation upon
target binding to aptamer films, properties from which mass
differences can be calculated. Özalp performed the method by
initially immobilizing biotin-labeled aptamers via avidin onto
a gold surface. A decrease in frequency and an increase in
dissipation energy were observed when target was added. With
frequency and dissipation data, and a viscoelastic representation
of the film, small mass changes on the surface were resolved. This
method was able to detect ATP at low concentrations, is a rapid
technique, and has been shown to work perform well in serum as
well as buffers.
The method of Osypova et al. is quite similar to that of Özalp
although it takes advantage of the change in conformation of the
aptamer upon target binding and the effect that has on hydration
of the sensing layer. By using a QCM-D with spectroscopic
ellipsometry the thickness, refractive index, optical mass, acoustic
mass, and hydration of the aptamer layer can be measured all
at once. QCM-D measures the mass uptake of the target to the
aptamer but also includes the mass of water hydrodynamically
bound to the aptamer. Upon target binding to the immobilized
aptamer, the aptamer undergoes a conformational modification,
which decreases the aptamer monolayer thickness resulting in
the release of measurable water to which it was coupled. QCM-D
can therefore detect the release of water. By taking into account
the mass of water, this method becomes more sensitive than
optical techniques that rely on refractive index measurements
that only measure the mass of the adsorbed molecule. As a
result, the method becomes sensitive enough for detection of
small molecules. On a side note, although this method is sensitive
and can detect small molecules with masses below 200 g/mol, it
requires aptamers that change conformation upon binding with
the target for successful detection.
Similarly, another interesting method for detecting small
molecules is a proof-of-concept work with an electromagnetic
piezoelectric acoustic sensor (EMPAS). Neves et al. (2015)
performed this method for the detection of cocaine (MW:
303.3 g/mol). The aptamer was immobilized onto an electrode-
free piezoelectric surface, namely quartz substrate sensing
platform, via a linker known as S-(11-tri- chlorosilyl-undecanyl)-
benzenethiosulfonate. To minimize steric hindrance due to
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tightly packed aptamers, MCH was added to react with the
linker and provide spacing. This spacing would allow for better
binding of the target to the aptamer. The excitation of the
acoustic resonance due to an external magnetic field produced
by a spiral coil 30 µm underneath the quartz substrate occurs
at a distance, which allows the sensor to function at ultra-high
frequencies (>1 GHz). The distant excitation is what makes
this method unique from other piezoelectric sensors. The wide
frequency range allows for tweaking the signal-to-noise ratio,
thereby increasing sensitivity of the sensor. The acoustic wave
device allows for measurement of direct binding of the aptamer
and the target by changes in mass difference and without any
labeling required. Additionally, this proof-of-concept method
uses an aptamer which only changes its tertiary structure upon
target binding. Its secondary structure is already folded before
the target, and there are no considerable changes in secondary
structure upon binding, thereby indicating that this method does
not rely on structure switching in order to perform well, as the
case with other sensors. In this method, the aptamer bound
cocaine with an affinity comparable to what has been detected
using other techniques. While the sensor is not as sensitive as
others that use the current cocaine aptamer, this method is a one-
step process that does not require signal amplification, labeling,
or aptamer structure-switching. When compared to methods
that do not amplify signals, this method fares comparably. This
method can also be regenerated for continuous use.
Finally, SPR can be challenging to adapt to small molecule
detection because it is a mass-sensitive technique. Normally,
SPR is used with large molecules that result in large changes in
refractive index induced by binding to the aptamer on the surface.
Nonetheless, Park et al. (2014) were able to apply it to small
molecules using localized SPR (LSPR) for the detection OTA.
Here, label-free LSPR is used to detect the binding of the target
to aptamers immobilized on the surface of gold nanorods. Again,
this method takes advantage of a conformational change in
structure of the aptamer upon target binding, thus the aptamer of
choice self-assembles into a G-quadruplex upon interaction with
OTA. The geometric change associated with formation of the G-
quadruplex induces a red shift of the LSPR peak as a consequence
of a refractive index change occurring at the gold nanorod
surface. The change in shape upon target interaction increases
the density of the surface and decreases the thickness which,
in combination the stability provided by having the aptamer
close to the surface of the nanoparticle, leads to augmented
LSPR wavelength shift and ultimately a more sensitive sensor.
A linear response was found for LSPR redshifts as a function of
OTA concentrations. Not only is this sensor sensitive, it can be
regenerated for re-use over 7 times. This method label-free and
also functions well in corn samples spiked with OTA.
These recent advances in aptasensor development for the
detection of small molecules are promising, with some having
overcome aforementioned obstacles such as the aptamer and
target mass difference, the need to label the aptamer, expensive
machinery, and time-consumingmethods.While the progression
is encouraging, more effort is needed for easier to use sensors
that avoid immobilization of the aptamer and target to allow free
equilibrium binding.
CONCLUSION
Recent advances have contributed to easier, quicker, and
more reliable methods for the selection, characterization, and
application of aptamers for small molecules. By modifying
SELEX and oligonucleotide structure, better selections have been
designed to produce aptamers that bind small molecules targets
with high affinity and specificity. Recent methods of screening
aptamers and characterizing their interactions with targets have
provided structure and alternatives to conventional methods,
along with the understanding that the method of characterization
chosen should match the application in which the aptamer would
be used for. This way the Kd from the test accurately reflects
the Kd in the application. Finally, approaches for aptamer-based
biosensors have overcome some aforementioned obstacles such
as the aptamer and target mass difference, the need to label the
aptamer, expensive machinery, and time-consuming tests. The
immobilization of the small target or oligonucleotide remains
one of the biggest impediments in developing an aptamer for
small molecules as free equilibrium binding is unachievable.
Nonetheless, many advancements are being made, and more
are likely to be made due to the ever-increasing popularity
of aptamers and the persistent need for detection of small
molecules in various industries for the protection of humans and
animals.
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